EFFECTIVENESS AND SAFETY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS VEDOLIZUMAB FORMULATION IN INFLAMMATORY BOWEL DISEASE PATIENTS IN CLINICAL REMISSION: A SINGLE CENTRE REAL WORLD EXPERIENCE

Laura Parisio  1     Carlo Romano Settanni  2     Simone Varca  3     Lucrezia Laterza  4     Loris Riccardo Lopetuso  5     Daniele Napolitano  6     Elisa Schiavoni  3     Laura Turchini  3     Caterina Fanali  3     Norma Alfieri  3     Marco Pizzoferrato  7     Alfredo Papa  8     Pia Clara Pafundi  3     Alessandro Armuzzi  9     Antonio Gasbarrini  10     Daniela Pugliese  4     Franco Scaldaferri  11    
1 IRCCS Fondazione Policlinico Gemelli Roma, Roma, Italy
2 Policlinico Gemelli - Rome, Jesi, Italy
3 Fondazione Policlinico Gemelli, Roma, Italy
4 Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy
5 Fondazione Policlinico Universitario "A. Gemelli" IRCCS - Università Cattolica di Roma, Roma, Italy
6 Policlinico Gemelli - Roma, Rome, Italy
7 UOC Medicina Gastroenterologia, Roma, Italy
8 Fondazione Policlinico Gemelli,IRCCS, Rome, Italy
9 IBD Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
10 Fondazione Policlinico Universitario Gemelli IRCCS, Università’ Cattolica, Rome, Italy
11 Catholic University of Rome Dept. of Internal Medicine Dept. of Gastroenterology, Roma, Italy

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing